Impact of SWI/SNF complex mutations in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors: Immuno-oncology biomarker study in LC-SCRUM-Japan (LC-SCRUM-IBIS).

Kiyotaka Yoh,Shingo Matsumoto,Naoki Furuya,Kazumi Nishino,Shingo Miyamoto,Satoshi Oizumi,Norio Okamoto,Hidetoshi Itani,Shoichi Kuyama,Atsushi Nakamura,Yuichiro Hayashi,Noriko Motoi,Genichiro Ishii,Koichi Goto

Impact of SWI/SNF complex mutations in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors: Immuno-oncology biomarker study in LC-SCRUM-Japan (LC-SCRUM-IBIS).

2020

Kiyotaka Yoh
Shingo Matsumoto
Naoki Furuya
Kazumi Nishino
Shingo Miyamoto
Satoshi Oizumi
Norio Okamoto
Hidetoshi Itani
Shoichi Kuyama
Atsushi Nakamura
Yuichiro Hayashi
Noriko Motoi
Genichiro Ishii
Koichi Goto

9530Background: The SWI/SNF chromatin remodeling complex is reported to be involved in sensitivity and resistance to immune checkpoint inhibitor (ICI). However, their role in non-small cell lung ca...

Keywords:

Oncology
SWI/SNF complex
Internal medicine
immune checkpoint inhibitors
Biomarker (medicine)
Ibis
in patient
non-small cell lung cancer (NSCLC)
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations